| Head and Neck Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 207show all (up to 200) |
|---|
| → investigated in trials for | Cisplatinsmall molecule 276 trials (122 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 276 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 212 trials (103 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 212 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 118 trials (29 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 118 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 98 trials (48 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 89 trials (31 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 87 trials (36 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 74 trials (37 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 65 trials (21 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 63 trials (39 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 42 trials (33 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 38 trials (19 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 32 trials (19 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 28 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 28 trials (20 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 27 trials (8 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 24 trials (15 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 23 trials (16 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 20 trials (9 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 19 trials (10 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 15 trials (10 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenib/Trametinib Regimen 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxel Liposome 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temoporfinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-EGFR Monoclonal Antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumab/Tremelimumab Regimen 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Poziotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisotumab Vedotinadc 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camonsertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacomitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Beta-1aother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nogapendekin Alfa Inbakiceptother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Patritumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pexidartinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Doublet 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Raltitrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rovalpituzumab Tesirineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sulindacsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Carcinoma | 1 | Observed | clinicaltrials | graph → |